Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: A planned safety analysis in 1 864 patients(legacy) | 196 |
| Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: A planned safety analysis in 1 864 patients(legacy) | 121 |
Total Visits per Month
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|
| Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: A planned safety analysis in 1 864 patients | 2 | 4 | 0 | 6 | 7 | 4 | 3 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| Australia | 73 |
| United States | 65 |
| China | 22 |
| Germany | 19 |
| France | 9 |
| Netherlands | 8 |
| Vietnam | 6 |
| Argentina | 4 |
| Hong Kong SAR China | 2 |
| Singapore | 2 |
Top City Views
| Views | |
|---|---|
| Kaleen | 41 |
| Ashburn | 23 |
| Rotterdam | 8 |
| Fairfield | 7 |
| Hanoi | 6 |
| Zhengzhou | 5 |
| Beijing | 4 |
| Boardman | 3 |
| Seattle | 3 |
| Central | 2 |